Bioventus Revenue and Competitors

Location

$545M

Total Funding

Estimated Revenue & Valuation

  • Bioventus's estimated annual revenue is currently $583.5M per year.(i)
  • Bioventus's estimated revenue per employee is $401,600
  • Bioventus's total funding is $545M.

Employee Data

  • Bioventus has 1453 Employees.(i)
  • Bioventus grew their employee count by 0% last year.

Bioventus's People

NameTitleEmail/Phone
1
Division VP, Restorative TherapiesReveal Email/Phone
2
Area VP SalesReveal Email/Phone
3
Area VP at Bioventus SurgicalReveal Email/Phone
4
Market Access: VP Corporate AccountsReveal Email/Phone
5
VP Customer ExperienceReveal Email/Phone
6
SVP Business Development and StrategyReveal Email/Phone
7
VP Marketing and Inside SalesReveal Email/Phone
8
VP Sales, Pain Treatment DivisionReveal Email/Phone
9
VP, MarketingReveal Email/Phone
10
VP, Accounting at Bioventus LLCReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31800M1095784%$367M$146B
Add Company

What Is Bioventus?

Bioventus LLC is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. With customers throughout the world and more than 500 employees, Bioventus is a global leader in active orthopaedic healing.

keywords:N/A

$545M

Total Funding

1453

Number of Employees

$583.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bioventus News

2022-04-17 - Bioventus Announces Preliminary First Quarter Net Sales and ...

Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for...

2022-04-17 - Bioventus Announces $415 Million Offering of Senior Notes

Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for...

2022-03-30 - Bioventus Exercises Call Option to Acquire CartiHeal

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by...

2021-11-09 - Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

DURHAM, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for three and nine months ended October 2, 2021. Q3 Financial Summary & Recent Highlights: Net Sales ...

2021-11-09 - Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance - Form 8-K

Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance DURHAM, NC - November 9, 2021 - Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for three and nine months ended Oct ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$336.9M1676N/AN/A
#2
$564.3M183210%N/A
#3
N/A1920-7%$30M
#4
$300M19485%N/A
#5
$315.6M20369%N/A